Microalgae-MOF integrated drug delivery system for cranial radiotherapy and chemotherapy-induced brain injury
Biomaterials · 2026-04 · 327 · 123767
DOI: 10.1016/j.biomaterials.2025.123767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials, 2026-04. Verfasst von Xuejiao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Department of Radiology, Affiliated Hang…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Metal-Organic Frameworks, Brain Injuries, Microalgae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Westlake University, National Key Research and Development Program of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The combination of cranial radiotherapy and chemotherapy may cause brain damage and cognitive dysfunction, therefore developing protective strategies for the treatment of chemoradiotherapy-induced brain injury is of great significance. Deferoxamine is an efficient iron chelator to inhibit ferroptosis which induced by radiotherapy and chemotherapy, but it has low oral bioavailability and difficulty in crossing the blood brain barrier (BBB), which limit its clinical translation. Herein, we constructed an orally microalgae-metal-organic framework (MOF) integrated drug delivery system (DFO@MOF@SP) for the protection of chemoradiotherapy-induced ferroptosis-related brain injury. Spirulina platensis (SP) can improve the biodistribution of nano-drugs in the intestines and enhance their oral bioavailability. The MOF nanoparticles as vectors for the delivery of deferoxamine (DFO), and modified by Angiopep-2 to improve their ability to cross the BBB (DFO@MOF). The in vitro and in vivo experimental results displayed that DFO@MOF@SP system has high safety and can exert good neuroprotective effect. We confirmed that DFO@MOF@SP system could improve the cognitive function and alleviate neurogenesis impairment and glial activation in mice subjected to chemoradiotherapy, and its neuroprotective mechanisms mainly include inhibiting ferroptosis and regulating gut microbiota. This study can provide new direction for the treatment of brain injury in patients undergoing cranial radiotherapy and chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Department of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine,…
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Department of Anesthesiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310…
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
- Department of Anesthesiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China. Electronic address: xiejunran@zju.edu.cn.
- Department of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310006, China. Electronic address: hangzhoudzx73@126.com.
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China; Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medic…
Förderung
- National Natural Science Foundation of China
- Westlake University
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research
- Zhejiang University
- Natural Science Foundation of Shandong Province
Zitieren
APA
Li, X., Ye, J., Zhong, D., Xie, J., Ding, Z., & Zhou, M. (2026). Microalgae-MOF integrated drug delivery system for cranial radiotherapy and chemotherapy-induced brain injury. Biomaterials, 327, 123767. https://doi.org/10.1016/j.biomaterials.2025.123767
Vancouver
Li X, Ye J, Zhong D, Xie J, Ding Z, Zhou M. Microalgae-MOF integrated drug delivery system for cranial radiotherapy and chemotherapy-induced brain injury. Biomaterials. 2026;327:123767. doi:10.1016/j.biomaterials.2025.123767
BibTeX
@article{Li2026,
author = {Li, Xuejiao and Ye, Jiahui and Zhong, Danni and Xie, Junran and Ding, Zhongxiang and Zhou, Min},
title = {Microalgae-MOF integrated drug delivery system for cranial radiotherapy and chemotherapy-induced brain injury},
journal = {Biomaterials},
year = {2026},
volume = {327},
pages = {123767},
doi = {10.1016/j.biomaterials.2025.123767}
}
EUVIMED